On the other hand, TOX3 has generally been regarded as a gene associated with ER + breast cancer since higher mRNA and protein expression of TOX3 have been observed in ER + BC cell lines compared to ER- cell lines, as well as larger SNP effect sizes for the risk of developing ER + compared to ER- BC [69–71]. The gene discussed is TOX3; the disease is breast carcinoma.